Zydus Lifesciences shares remained in focus after the company received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its...
Shares of Zydus Lifesciences Ltd soared 5% on 14 May after it announced a major strategic acquisition by signing a definitive agreement to acquire Assertio...
Shares of Zydus Lifesciences Ltd soared 3% higher on 12 February after the company announced settling a dispute with Astellas Pharma. Zydus Lifesciences and its...
Zydus Lifesciences has added another regulatory milestone to its record, securing a clean USFDA report for its Ahmedabad SEZ-II facility. The development comes just days...
Shares of Zydus Lifesciences Ltd are trading flat after hitting a day’s high of Rs 980.55 on 3rd November. This follows the company’s disclosure that...